CliffBio
small molecule

DESIPRAMINE HYDROCHLORIDE

DESIPRAMINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand nameDESIPRAMINE HYDROCHLORIDE
Active ingredientDESIPRAMINE HYDROCHLORIDE
Strength75MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2021
Marketing statusRX

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.